{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:33:39Z","timestamp":1757540019908,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by the Third Affiliated Hospital of Sun Yat-sen University, Clinical Research Program","award":["No. YHJH201908"],"award-info":[{"award-number":["No. YHJH201908"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02363-7","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:18:18Z","timestamp":1747736298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Late course adaptive radiotherapy based on tumor volume reduction decreases Gastrointestinal toxicity for abdominal lymph node metastasis of hepatocellular carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Huamei","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fantu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"3","key":"2363_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"2363_CR2","first-page":"251","volume":"49","author":"National Health Commission of the People\u2019s Republic of China","year":"2022","unstructured":"National Health Commission of the People\u2019s Republic of China. Standardization for diagnosis and treatment of primary hepatic carcinoma (2022 Edition). Cancer Res. Prev. Treat. 49 (3), 251\u2013276 (2022).","journal-title":"Cancer Res. Prev. Treat."},{"issue":"4","key":"2363_CR3","doi-asserted-by":"publisher","first-page":"e95889","DOI":"10.1371\/journal.pone.0095889","volume":"9","author":"F Xia","year":"2014","unstructured":"Xia, F. et al. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One. 9 (4), e95889 (2014).","journal-title":"PLoS One"},{"issue":"4","key":"2363_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ans.15096","volume":"89","author":"A Yang","year":"2019","unstructured":"Yang, A. et al. Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma. ANZ J. Surg. 89 (4), 393\u2013398 (2019).","journal-title":"ANZ J. Surg."},{"issue":"3","key":"2363_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cam4.1948","volume":"8","author":"JR Robbins","year":"2019","unstructured":"Robbins, J. R., Schmid, R. K., Hammad, A. Y., Gamblin, T. C. & Erickson, B. A. Stereotactic body radiation therapy for hepatocellular carcinoma: practice patterns, dose selection and factors impacting survival. Cancer Med. 8 (3), 928\u2013938 (2019).","journal-title":"Cancer Med."},{"issue":"10","key":"2363_CR6","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00432-018-2729-y","volume":"144","author":"S Lazarev","year":"2018","unstructured":"Lazarev, S., Hardy-Abeloos, C., Factor, O., Rosenzweig, K. & Buckstein, M. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities. J. Cancer Res. Clin. Oncol. 144 (10), 2077\u20132083 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"2363_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.21037\/apm.2019.11.17","volume":"8","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Image-guided intensity-modulated radiotherapy improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma. Ann. Palliat. Med. 8 (5), 717\u2013727 (2019).","journal-title":"Ann. Palliat. Med."},{"issue":"5","key":"2363_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/jrr\/rraa067","volume":"61","author":"M Matoba","year":"2020","unstructured":"Matoba, M., Tsuchiya, H., Kondo, T. & Ota, K. Stereotactic body radiotherapy delivered with IMRT for oligometastatic regional lymph node metastases in hepatocellular carcinoma: a single-institutional study. J. Radiat. Res. 61 (5), 776\u2013783 (2020).","journal-title":"J. Radiat. Res."},{"issue":"12","key":"2363_CR9","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/j.clon.2016.08.011","volume":"28","author":"ML Yap","year":"2016","unstructured":"Yap, M. L. et al. Adaptive dose escalation using serial Four-dimensional positron emission tomography\/computed tomography scans during radiotherapy for locally advanced Non-small cell lung Cancer. Clin. Oncol. (R Coll. Radiol). 28 (12), e199\u2013e205 (2016).","journal-title":"Clin. Oncol. (R Coll. Radiol)"},{"issue":"1","key":"2363_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12957-024-03399-1","volume":"22","author":"H Yan","year":"2024","unstructured":"Yan, H. et al. Microinvasion in hepatocellular carcinoma: predictive factor and application for definition of clinical target volume for radiotherapy. World J. Surg. Oncol. 22 (1), 125 (2024).","journal-title":"World J. Surg. Oncol."},{"key":"2363_CR11","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma, D. A. et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-Term results of the journal Pre-proo26 SABR-COMET phase II randomized trial. J. Clin. Oncol. 38, 2830\u20132838 (2020).","journal-title":"J. Clin. Oncol."},{"key":"2363_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","volume":"114","author":"S Harrow","year":"2022","unstructured":"Harrow, S. et al. Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended Long-Term outcomes. Int. J. Radiat. Oncol. Biol. Phys. 114, 611\u2013616 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"2363_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00066-015-0873-8","volume":"191","author":"DY Lee","year":"2015","unstructured":"Lee, D. Y. et al. Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma [J]. Strahlenther Onkol. 191 (11), 835\u2013844 (2015).","journal-title":"Strahlenther Onkol"},{"key":"2363_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jjco\/hyac028","volume":"52","author":"IY Jo","year":"2022","unstructured":"Jo, I. Y. et al. Stereotactic ablative radiotherapy for pulmonary oligometastases from primary hepatocellular carcinoma: a multicenter and retrospective analysis (KROG 17\u2009\u2013\u200908). Jpn J. Clin. Oncol. 52, 616\u2013622 (2022).","journal-title":"Jpn J. Clin. Oncol."},{"issue":"4","key":"2363_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ijrobp.2005.03.058","volume":"63","author":"ZC Zeng","year":"2005","unstructured":"Zeng, Z. C. et al. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int. J. Radiat. Oncol. Biol. Phys. 63 (4), 1067\u20131076 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"2363_CR16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00535-006-1895-x","volume":"41","author":"YJ Park","year":"2006","unstructured":"Park, Y. J. et al. Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J. Gastroenterol. 41 (11), 1099\u20131106 (2006).","journal-title":"J. Gastroenterol."},{"issue":"10","key":"2363_CR17","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/cncr.26586","volume":"118","author":"J Welsh","year":"2012","unstructured":"Welsh, J. et al. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118 (10), 2632\u20132640 (2012).","journal-title":"Cancer"},{"issue":"3","key":"2363_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.radonc.2017.04.002","volume":"123","author":"H Yamashita","year":"2017","unstructured":"Yamashita, H., Abe, O. & Nakagawa, K. Involved-field irradiation concurrently combined with nedaplatin\/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study. Radiother Oncol. 123 (3), 488 (2017).","journal-title":"Radiother Oncol."},{"issue":"6","key":"2363_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00066-021-01750-z","volume":"197","author":"C Ostheimer","year":"2021","unstructured":"Ostheimer, C. et al. Correction to: prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the young DEGRO trial group. Strahlenther Onkol. 197 (6), 560\u2013561 (2021).","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"2363_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.7785\/tcrt.2012.500310","volume":"12","author":"X Ding","year":"2013","unstructured":"Ding, X. et al. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET\/CT for stage III non-small cell lung cancer. Technol. Cancer Res. Treat. 12 (3), 251\u2013257 (2013).","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"2363_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2008.07.063","volume":"74","author":"J Fox","year":"2009","unstructured":"Fox, J. et al. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 74 (2), 341\u2013348 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"2363_CR22","first-page":"266","volume":"35","author":"G Yang","year":"2023","unstructured":"Yang, G. et al. Advancements in Understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review. Chin. J. Cancer Res. 35 (3), 266\u2013282 (2023).","journal-title":"Chin. J. Cancer Res."},{"issue":"1","key":"2363_CR23","doi-asserted-by":"publisher","first-page":"e0170901","DOI":"10.1371\/journal.pone.0170901","volume":"12","author":"L Xiao","year":"2017","unstructured":"Xiao, L. et al. Late-Course adaptive adjustment based on metabolic tumor volume changes during radiotherapy May reduce radiation toxicity in patients with Non-Small cell lung Cancer. PLoS One. 12 (1), e0170901 (2017). Published 2017 Jan 26.","journal-title":"PLoS One"},{"issue":"4","key":"2363_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.ijrobp.2005.11.012","volume":"64","author":"CR Ramsey","year":"2006","unstructured":"Ramsey, C. R. et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 64 (4), 1237\u20131244 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"2363_CR25","first-page":"970","volume":"Jul;31","author":"Zhang","year":"2018","unstructured":"Zhang Zhu ling-xiao, Shi xue-bing. Dosimetric study of reducing IMRT field by secondary positioning adjustment in esophageal carcinoma. Chin. J. Clin. Res. Jul;31 (7), 970\u2013972 (2018).","journal-title":"Chin. J. Clin. Res."},{"issue":"6","key":"2363_CR26","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1093\/oncolo\/oyad083","volume":"28","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Efficacy and Dose-Response relationship of stereotactic body radiotherapy for abdominal lymph node metastases from hepatocellular carcinoma. Oncologist 28 (6), e369\u2013e378 (2023).","journal-title":"Oncologist"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02363-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:18:19Z","timestamp":1747736299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02363-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02363-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University, Approval No. II2024-040-01.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}],"article-number":"17477"}}